These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment]. Shitara N, Nakamura H, Genka S, Takakura K. Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704 [Abstract] [Full Text] [Related]
23. [Clinical trials of interferon-beta (MR-21) on malignant brain tumors]. Takakura K. Nihon Gan Chiryo Gakkai Shi; 1987 May 20; 22(4):801-8. PubMed ID: 3312440 [No Abstract] [Full Text] [Related]
24. Clinical trial end points in malignant glioma: need for effective trial design strategy. Brada M, Yung WK. Semin Oncol; 2000 Jun 20; 27(3 Suppl 6):11-9. PubMed ID: 10866345 [Abstract] [Full Text] [Related]
25. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH. Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4294-305. PubMed ID: 16857805 [Abstract] [Full Text] [Related]
27. [Supratentorial malignant glioma in adults. Adjustment of the treatment of 3 groups according to a clinical classification]. Caudry M, Maire JP, Guerin J, Celerier D, Demeaux H, Banayan A, Leman P. Sem Hop; 1983 Feb 17; 59(7):453-8. PubMed ID: 6302884 [Abstract] [Full Text] [Related]
35. [In vitro induction of PHA-activated killer cells for adoptive immunotherapy of recurrent or residual malignant gliomas]. Shinoda J, Yamada H, Sakai N, Ando T, Miwa Y. Neurol Med Chir (Tokyo); 1987 Sep 17; 27(9):831-40. PubMed ID: 2451171 [No Abstract] [Full Text] [Related]
36. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications. Yang MY, Zetler PM, Prins RM, Khan-Farooqi H, Liau LM. Expert Rev Neurother; 2006 Oct 17; 6(10):1481-94. PubMed ID: 17078788 [Abstract] [Full Text] [Related]
37. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy. Mahaley MS, Gillespie GY. Clin Neurosurg; 1983 Oct 17; 31():456-69. PubMed ID: 6680086 [No Abstract] [Full Text] [Related]
38. Tumor vaccination for high-grade glioma. Schlegel PG, Eyrich M, Kramm C, van Gool S. Pediatr Blood Cancer; 2010 Dec 15; 55(7):1437. PubMed ID: 20848641 [No Abstract] [Full Text] [Related]
39. Intralymphatic immunotherapy of glioblastoma. Eggers AE, Miller JI, Sclafani S. N Y State J Med; 1992 Jun 15; 92(6):272-4. PubMed ID: 1641215 [No Abstract] [Full Text] [Related]